151 related articles for article (PubMed ID: 35541930)
1. Site-specific anchoring aptamer C2NP on DNA origami nanostructures for cancer treatment.
Sun P; Zhang N; Tang Y; Yang Y; Zhou J; Zhao Y
RSC Adv; 2018 Jul; 8(46):26300-26308. PubMed ID: 35541930
[TBL] [Abstract][Full Text] [Related]
2. Synergistic Treatment of Tumor by Targeted Biotherapy and Chemotherapy via Site-Specific Anchoring of Aptamers on DNA Nanotubes.
Chen R; Sun P; Chu X; Pu X; Yang Y; Zhang N; Zhao Y
Int J Nanomedicine; 2020; 15():1309-1320. PubMed ID: 32161460
[TBL] [Abstract][Full Text] [Related]
3. Aptamer-Functionalized DNA Origami for Targeted Codelivery of Antisense Oligonucleotides and Doxorubicin to Enhance Therapy in Drug-Resistant Cancer Cells.
Pan Q; Nie C; Hu Y; Yi J; Liu C; Zhang J; He M; He M; Chen T; Chu X
ACS Appl Mater Interfaces; 2020 Jan; 12(1):400-409. PubMed ID: 31815420
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Functional Properties of Three DNA Origami Nanostructures as Doxorubicin Carriers to Breast Cancer Cells.
Udomprasert A; Wootthichairangsan C; Duangrat R; Chaithongyot S; Zhang Y; Nixon R; Liu W; Wang R; Ponglikitmongkol M; Kangsamaksin T
ACS Appl Bio Mater; 2022 May; 5(5):2262-2272. PubMed ID: 35500214
[TBL] [Abstract][Full Text] [Related]
5. SL2B aptamer and folic acid dual-targeting DNA nanostructures for synergic biological effect with chemotherapy to combat colorectal cancer.
Sun P; Zhang N; Tang Y; Yang Y; Chu X; Zhao Y
Int J Nanomedicine; 2017; 12():2657-2672. PubMed ID: 28435250
[TBL] [Abstract][Full Text] [Related]
6. Targeted Therapy of Colon Cancer by Aptamer-Guided Holliday Junctions Loaded with Doxorubicin.
Yao F; An Y; Li X; Li Z; Duan J; Yang XD
Int J Nanomedicine; 2020; 15():2119-2129. PubMed ID: 32280210
[TBL] [Abstract][Full Text] [Related]
7. Aptamer-based targeted delivery systems for cancer treatment using DNA origami and DNA nanostructures.
Jabbari A; Sameiyan E; Yaghoobi E; Ramezani M; Alibolandi M; Abnous K; Taghdisi SM
Int J Pharm; 2023 Nov; 646():123448. PubMed ID: 37757957
[TBL] [Abstract][Full Text] [Related]
8. DNA origami as an in vivo drug delivery vehicle for cancer therapy.
Zhang Q; Jiang Q; Li N; Dai L; Liu Q; Song L; Wang J; Li Y; Tian J; Ding B; Du Y
ACS Nano; 2014 Jul; 8(7):6633-43. PubMed ID: 24963790
[TBL] [Abstract][Full Text] [Related]
9. PrP
Go G; Lee CS; Yoon YM; Lim JH; Kim TH; Lee SH
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671292
[TBL] [Abstract][Full Text] [Related]
10. Time-lapse live cell imaging to monitor doxorubicin release from DNA origami nanostructures.
Zeng Y; Liu J; Yang S; Liu W; Xu L; Wang R
J Mater Chem B; 2018 Mar; 6(11):1605-1612. PubMed ID: 30221004
[TBL] [Abstract][Full Text] [Related]
11. Enhanced cancer therapy with pH-dependent and aptamer functionalized doxorubicin loaded polymeric (poly D, L-lactic-co-glycolic acid) nanoparticles.
Saravanakumar K; Hu X; Shanmugam S; Chelliah R; Sekar P; Oh DH; Vijayakumar S; Kathiresan K; Wang MH
Arch Biochem Biophys; 2019 Aug; 671():143-151. PubMed ID: 31283911
[TBL] [Abstract][Full Text] [Related]
12. DNA origami/gold nanorod hybrid nanostructures for the circumvention of drug resistance.
Song L; Jiang Q; Liu J; Li N; Liu Q; Dai L; Gao Y; Liu W; Liu D; Ding B
Nanoscale; 2017 Jun; 9(23):7750-7754. PubMed ID: 28581004
[TBL] [Abstract][Full Text] [Related]
13. Aptamers with Self-Loading Drug Payload and pH-Controlled Drug Release for Targeted Chemotherapy.
Zeng Z; Qi J; Wan Q; Zu Y
Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452182
[TBL] [Abstract][Full Text] [Related]
14. A Novel AS1411 Aptamer-Based Three-Way Junction Pocket DNA Nanostructure Loaded with Doxorubicin for Targeting Cancer Cells in Vitro and in Vivo.
Taghdisi SM; Danesh NM; Ramezani M; Yazdian-Robati R; Abnous K
Mol Pharm; 2018 May; 15(5):1972-1978. PubMed ID: 29669200
[TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of doxorubicin through CD44 aptamer to cancer cells.
Natesh J; Chandola C; Meeran SM; Neerathilingam M
Ther Deliv; 2021 Oct; 12(10):693-703. PubMed ID: 34592836
[No Abstract] [Full Text] [Related]
16. Facile Construction of i-Motif DNA-Conjugated Gold Nanostars as Near-Infrared and pH Dual-Responsive Targeted Drug Delivery Systems for Combined Cancer Therapy.
Miao D; Yu Y; Chen Y; Liu Y; Su G
Mol Pharm; 2020 Apr; 17(4):1127-1138. PubMed ID: 32092274
[TBL] [Abstract][Full Text] [Related]
17. Immune lipoprotein nanostructures inspired relay drug delivery for amplifying antitumor efficiency.
Han Y; Ding B; Zhao Z; Zhang H; Sun B; Zhao Y; Jiang L; Zhou J; Ding Y
Biomaterials; 2018 Dec; 185():205-218. PubMed ID: 30245388
[TBL] [Abstract][Full Text] [Related]
18. Efficient Intracellular Delivery of RNase A Using DNA Origami Carriers.
Zhao S; Duan F; Liu S; Wu T; Shang Y; Tian R; Liu J; Wang ZG; Jiang Q; Ding B
ACS Appl Mater Interfaces; 2019 Mar; 11(12):11112-11118. PubMed ID: 30874429
[TBL] [Abstract][Full Text] [Related]
19. Aptamer-mediated doxorubicin delivery reduces HCC burden in 3D organoids model.
Zhou K; Huo X; Nguyen R; Bae SDW; Han S; Zhang Z; Duan W; Yuen L; Lam V; George J; Qiao L
J Control Release; 2022 Jan; 341():341-350. PubMed ID: 34848243
[TBL] [Abstract][Full Text] [Related]
20. Aptamer-drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity.
Dou XQ; Wang H; Zhang J; Wang F; Xu GL; Xu CC; Xu HH; Xiang SS; Fu J; Song HF
Int J Nanomedicine; 2018; 13():763-776. PubMed ID: 29440899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
